Corbus Pharmaceuticals ( (CRBP) ) just unveiled an update.
On March 13, 2025, Corbus Pharmaceuticals appointed Ian Hodgson as Chief Operating Officer, effective March 15, 2025. Hodgson, with over 25 years of experience in drug development, previously served as Head of Operations at Corbus and has held various leadership roles in the biotech and pharmaceutical sectors. His appointment is accompanied by a Service Agreement that outlines his compensation and employment terms, including non-compete clauses and provisions for termination under specific circumstances.
More about Corbus Pharmaceuticals
Corbus Pharmaceuticals Holdings, Inc. operates in the biotechnology industry, focusing on drug development and operations. The company is involved in developing therapies for rare diseases and has a market focus on innovative treatments.
YTD Price Performance: -42.19%
Average Trading Volume: 251,678
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $83.06M
See more data about CRBP stock on TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com